Absorption, Metabolism, and Excretion of Paliperidone, a New Monoaminergic Antagonist, in Humans

@article{Vermeir2008AbsorptionMA,
  title={Absorption, Metabolism, and Excretion of Paliperidone, a New Monoaminergic Antagonist, in Humans},
  author={M. Vermeir and I. Naessens and B. Remmerie and G. Mannens and Jan F. A. Hendrickx and P. Sterkens and K. Talluri and S. Boom and M. Eerdekens and N. van Osselaer and A. Cleton},
  journal={Drug Metabolism and Disposition},
  year={2008},
  volume={36},
  pages={769 - 779}
}
Absorption, metabolism, and excretion of paliperidone, an atypical antipsychotic, was studied in five healthy male subjects after a single dose of 1 mg of [14C]paliperidone oral solution (∼16 μCi/subject). One week after dosing, 88.4 to 93.8% (mean 91.1%) of the administered radioactivity was excreted: 77.1 to 87.1% (mean 79.6%) in urine and 6.8 to 14.4% (mean 11.4%) in the feces. Paliperidone was the major circulating compound (97% of the area under the plasma concentration-time curve at 24 h… Expand

Paper Mentions

Interventional Clinical Trial
The purposes of this study are to investigate the metabolic pathways of paliperidone and excretion of paliperidone and its metabolites in healthy adult male volunteers, both CYP2D6… Expand
ConditionsSchizophrenia
InterventionDrug
Interaction Between Paliperidone and Carbamazepine
The pharmacology and formulation of paliperidone extended release
Pharmacokinetics of felbinac after intravenous administration of felbinac trometamol in rats
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
Absorption, metabolism, and excretion of risperidone in humans.
Plasma protein binding of risperidone and its distribution in blood
Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4
Efficacy and Safety of Paliperidone Extended-Release Tablets: Results of a 6-Week, Randomized, Placebo-Controlled Study
Paliperidone Extended Release
Validated method for the determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography-tandem mass spectrometry.
...
1
2
3
4
...